Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MydCombi for Pupillary Dilation
NCT06366217Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Mydriasert, sponsored by University of California, San Francisco. Started Oct 2024; status: completed.
02
Drugs
Mydriasert
Beyond the preview
Go deeper on NCT06366217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06366217.